TrialThe New England journal of medicine2017
Teprotumumab for Thyroid-Associated Ophthalmopathy.
Terry J Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
334 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialThe New England journal of medicine2017
Terry J Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.